Thursday, 28 July 2016 22:30
Interactions of CNS G-protein signaling and renal nerve activity in hypertension
Tuesday, 31 May 2016 10:23
Tuesday, 31 May 2016 10:20
Monday, 04 April 2016 16:27
Monday, 04 April 2016 16:24
Wednesday, 24 February 2016 22:40
Monday, 08 February 2016 12:02
Surgical intervention for urolithiasis: does it result in long-term medical complications?
By Amy Krambeck
Monday, 08 February 2016 11:59
Monday, 30 November 2015 12:00
TGF-beta/Smad signaling pathway in hypertensive kidney and cardiovascular diseases
By Hui Yao Lan
Monday, 30 November 2015 09:54
Neuroimmune communication in hypertension and obesity: A new therapeutic angle?
By YanFei Qi
Monday, 30 November 2015 09:46
Autonomic regulation of the immune system and its implications for hypertension
Thursday, 05 November 2015 11:49
Efficacy of Kinkeliba in non-complicated hypertensive patients: a randomized controlled trial
By Sidy Seck
Wednesday, 28 October 2015 23:57
Neurocognitive alterations in hypertensive children and adolescents
By Marc Lande
Friday, 03 July 2015 14:04
Hypertension and kidney disease: The fault is not in our stars, but may be in our embryos
Thursday, 23 April 2015 22:34
ENDOPLASMIC RETICULUM STRESS INHIBITION PREVENTS THE DEVELOPMENT OF ESSENTIAL HYPERTENSION
Thursday, 23 April 2015 22:32
An anthropologic view of the metabolic syndrome: The back-to-Africa hypothesis
Monday, 03 November 2014 00:54
Role of Rac1 in podocyte injury and glomerulosclerosis audioicon
By Miki Nagase
Monday, 03 November 2014 00:49
Salt transporters in the kidney during hypertension: matching Na output to intake audioicon
Monday, 03 November 2014 00:47
Regulation of sodium excretion by Inflammatory cells audioicon
By Jens Titze
Monday, 03 November 2014 00:38
Monday, 03 November 2014 00:34
Beyond the RAS: for the prevention of nephropathy in diabetes audioicon
By Mark Cooper
Monday, 03 November 2014 00:32
Fetal programming, nephron number and hypertension audioicon
By Karen Moritz
Monday, 03 November 2014 00:27
Metabolomics Insights in Diabetic Renal Disease audioicon
By Kumar Sharma
Monday, 03 November 2014 00:25
Impact of SGLT2 inhibition in hypertension and diabetic nephropathy audioicon
Monday, 03 November 2014 00:23
Effects of the SGLT2 inhibitors on circadian blood pressure in metabolic syndrome audioicon
Monday, 03 November 2014 00:20
Vascular Actions of AT1 Angiotensin Receptors in Hypertension audioicon
Monday, 03 November 2014 00:17
The Renin-Angiotensin System in HTN: ACE2 in Hypertension audioicon
By Susan Gurley
Monday, 25 March 2013 13:06
Tuesday, 08 January 2013 16:16
Monday, 09 July 2012 13:37
Monday, 26 March 2012 09:40
Renal outcomes in hypertensive Black patients at high cardiovascular risk